Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Recommendation of “Buy” from Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been given an average recommendation of “Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have issued ratings […]
More Stories
Aleph Zero (AZERO) Price Down 16.8% Over Last 7 Days
Aleph Zero (AZERO) traded 6.3% lower against the dollar during the 24 hour period ending at 13:00 PM ET on...
JUNO (JUNO) Reaches 1-Day Trading Volume of $83,727.18
JUNO (JUNO) traded down 4.5% against the U.S. dollar during the 24-hour period ending at 13:00 PM E.T. on July...
McDonald’s Co. (NYSE:MCD) Shares Purchased by Core Wealth Partners LLC
Core Wealth Partners LLC lifted its position in McDonald’s Co. (NYSE:MCD – Free Report) by 4.2% during the first quarter,...
Casper Market Cap Tops $256.44 Million (CSPR)
Casper (CSPR) traded up 1.5% against the US dollar during the twenty-four hour period ending at 13:00 PM ET on...
Atomic Wallet Coin Hits 24-Hour Trading Volume of $1,772.81 (AWC)
Atomic Wallet Coin (AWC) traded down 4.1% against the dollar during the 24 hour period ending at 13:00 PM E.T....
ZRC Wealth Management LLC Acquires 4,870 Shares of Avantis International Equity ETF (NYSEARCA:AVDE)
ZRC Wealth Management LLC grew its position in Avantis International Equity ETF (NYSEARCA:AVDE – Free Report) by 3.7% in the...